Projects funded by the NCN
15-oxo-eicosatetraenoic acid (15-oxo-ETE) as a potential diagnostic biomarker of aspirin-exacerbated respiratory disease.
2021/41/B/NZ5/00305
Keywords:
aspirin-exacerbated respiratory disease 15-oxo-ETE in vitro diagnostic tests
Descriptors:
- NZ5_005:
Panel:
NZ5 - Human and animal noninfectious diseases: etiology, mechanisms, diagnosis and treatment of diseases, poisonings and injuries (without neurological diseases)
Host institution :
Uniwersytet Jagielloński, Collegium Medicum
woj. małopolskie
Principal investigator (from the host institution):
Number of co-investigators in the project: 8
Call: OPUS 21 - announced on 2021-03-15
Amount awarded: 818 660 PLN
Project start date (Y-m-d): 2022-01-13
Project end date (Y-m-d): 2025-01-12
Project duration:: 36 months (the same as in the proposal)
Project status: Project completed
Project description
Download the project description in a pdf file
Note - project descriptions were prepared by the authors of the applications themselves and placed in the system in an unchanged form.
Information in the final report
Publications will be made available after the final report has been accepted.